Hong T H, Chen S T, Tang T K, Wang S C, Chang T H
Cell Biology and Immunology Division, Development Center for Biotechnology, Taipei, Taiwan.
J Immunol Methods. 1989 Jun 21;120(2):151-7. doi: 10.1016/0022-1759(89)90236-6.
Two novel immunization methods (intrasplenic and intra-inguinal lymph node) have been developed for the production of polyclonal and monoclonal antibodies in mice. Freund's complete adjuvant and antigen were mixed in the ratio of 1:2 (v/v). Various concentrations of human serum albumin (HSA) were used as antigen. No primary immune response was induced with 0.1 microgram of HSA in either of the methods studied. Intrasplenic immunization resulted in the strongest primary immune responses using all other doses of HSA. The primary immune response induced by intrasplenic immunization with 0.5 microgram of HSA was higher than any response induced by subcutaneous immunization with various doses of HSA. Inguinal lymph node immunization was less effective than intrasplenic immunization but better than subcutaneous immunization with 1-50 micrograms of HSA. Comparisons were also made of the efficacy of different adjuvants when inducing primary immune responses with 1 microgram of HSA. Freund's complete adjuvant resulted in a much stronger response than Freund's incomplete adjuvant and alum. Both intrasplenic and inguinal lymph node immunization using 1-5 micrograms of HSA were able to induce strong primary immune responses. Secondary immunization with either method or intravenous injection 3 days before fusion resulted in a higher frequency of specific monoclonal antibodies.
已开发出两种新型免疫方法(脾内注射和腹股沟淋巴结内注射)用于在小鼠体内产生多克隆和单克隆抗体。弗氏完全佐剂和抗原按1:2(v/v)的比例混合。使用不同浓度的人血清白蛋白(HSA)作为抗原。在所研究的两种方法中,0.1微克HSA均未诱导出初次免疫反应。使用所有其他剂量的HSA时,脾内免疫产生的初次免疫反应最强。用0.5微克HSA进行脾内免疫诱导的初次免疫反应高于用不同剂量HSA进行皮下免疫诱导的任何反应。腹股沟淋巴结免疫比脾内免疫效果差,但比用1 - 50微克HSA进行皮下免疫效果好。还比较了用1微克HSA诱导初次免疫反应时不同佐剂的效果。弗氏完全佐剂比弗氏不完全佐剂和明矾产生的反应要强得多。使用1 - 5微克HSA进行脾内和腹股沟淋巴结免疫均能诱导强烈的初次免疫反应。在融合前3天,用任一种方法进行二次免疫或静脉注射可产生更高频率的特异性单克隆抗体。